-+ 0.00%
-+ 0.00%
-+ 0.00%

Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit

PUBT·05/27/2026 12:03:53
Listen to the news
Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit
  • Coya Therapeutics will present the ALSTARS Phase 2 trial design for COYA 302 at the 5th ALS Drug Development Summit in Boston, June 2-4, 2026.
  • A poster session is scheduled for June 3, 2026 at 4:45 p.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605270800BIZWIRE_USPR_____20260527_BW446509) on May 27, 2026, and is solely responsible for the information contained therein.